Mariko Tabata

438 total citations
12 papers, 148 citations indexed

About

Mariko Tabata is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mariko Tabata has authored 12 papers receiving a total of 148 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mariko Tabata's work include Cancer Genomics and Diagnostics (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Mariko Tabata is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Mariko Tabata collaborates with scholars based in Japan, United Kingdom and Sweden. Mariko Tabata's co-authors include Yasunori Kogure, Yuki Saito, Keisuke Kataoka, Takanori Kanai∥, Junji Koya, Marni B. McClure, Kota Yoshifuji, Sumito Shingaki, Yasushi Okuno and Shigeyuki Matsumoto and has published in prestigious journals such as Nature, Blood and Cancer Discovery.

In The Last Decade

Mariko Tabata

8 papers receiving 147 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mariko Tabata Japan 5 77 49 47 44 19 12 148
Jinyeong Lim South Korea 7 76 1.0× 46 0.9× 37 0.8× 42 1.0× 21 1.1× 18 157
Shanghua Jing China 10 128 1.7× 86 1.8× 57 1.2× 44 1.0× 25 1.3× 23 214
Maitri Kalra United States 6 65 0.8× 28 0.6× 84 1.8× 37 0.8× 33 1.7× 22 164
Stefania Pipitone Italy 7 56 0.7× 48 1.0× 101 2.1× 62 1.4× 24 1.3× 22 175
Sumito Shingaki Japan 4 87 1.1× 33 0.7× 35 0.7× 24 0.5× 8 0.4× 15 134
Sophie Shifman United States 3 69 0.9× 47 1.0× 66 1.4× 84 1.9× 15 0.8× 5 174
Kerstie Johnson United Kingdom 6 114 1.5× 42 0.9× 64 1.4× 27 0.6× 11 0.6× 12 163
Hasan Mirza United Kingdom 8 93 1.2× 61 1.2× 97 2.1× 33 0.8× 9 0.5× 19 198
L. Manahan United States 3 99 1.3× 45 0.9× 68 1.4× 36 0.8× 13 0.7× 4 179
Amanda J. Loch Canada 4 135 1.8× 44 0.9× 89 1.9× 63 1.4× 33 1.7× 5 210

Countries citing papers authored by Mariko Tabata

Since Specialization
Citations

This map shows the geographic impact of Mariko Tabata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariko Tabata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariko Tabata more than expected).

Fields of papers citing papers by Mariko Tabata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariko Tabata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariko Tabata. The network helps show where Mariko Tabata may publish in the future.

Co-authorship network of co-authors of Mariko Tabata

This figure shows the co-authorship network connecting the top 25 collaborators of Mariko Tabata. A scholar is included among the top collaborators of Mariko Tabata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariko Tabata. Mariko Tabata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Yoshifuji, Kota, Yuki Saito, Mariko Tabata, et al.. (2025). In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesis. Blood Advances. 9(19). 5040–5055.
2.
Saito, Yuki, Yasunori Kogure, Yuta Ito, et al.. (2024). Pan-Cancer Comparative and Integrative Analyses of Driver Alterations Using Japanese and International Genomic Databases. Cancer Discovery. 14(5). 786–803. 21 indexed citations
3.
McClure, Marni B., Yasunori Kogure, Naser Ansari‐Pour, et al.. (2023). Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer RevealsTP53Aneuploidy–driven Metabolic Reprogramming. Cancer Research Communications. 3(2). 281–296. 11 indexed citations
4.
Ito, Yuta, Joji Shimono, Keisuke Kawamoto, et al.. (2023). TP53 and CDKN2A alterations Define a Poor Prognostic Subgroup in Patients with Nodal T-Follicular Helper Cell Lymphoma. Blood. 142(Supplement 1). 1630–1630.
5.
Shingaki, Sumito, Junji Koya, Mitsuhiro Yuasa, et al.. (2022). Tumor-promoting function and regulatory landscape of PD-L2 in B-cell lymphoma. Leukemia. 37(2). 492–496. 1 indexed citations
6.
Yamada, Yukio, Tohru Nakagawa, Jimpei Miyakawa, et al.. (2021). Smaller decline of renal function after nephroureterectomy predicts poorer prognosis of upper tract urothelial carcinoma: a multicentre retrospective study. Japanese Journal of Clinical Oncology. 51(10). 1577–1586. 4 indexed citations
7.
Saito, Yuki, Junji Koya, Mitsugu Araki, et al.. (2020). Landscape and function of multiple mutations within individual oncogenes. Nature. 582(7810). 95–99. 84 indexed citations
8.
Saito, Yuki, Takuro Kameda, Yasunori Kogure, et al.. (2020). Dissecting Multicellular Ecosystems of HTLV-1 Infection and ATL By Multi-Omics Single Cell Analysis. Blood. 136(Supplement 1). 18–18.
9.
Naito, Akihiro, Satoru Taguchi, Tohru Nakagawa, et al.. (2016). Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladder. World Journal of Urology. 35(1). 97–103. 10 indexed citations
10.
Tabata, Mariko, Masaomi Ikeda, Shinji Urakami, et al.. (2015). Impact of adjuvant chemotherapy on patients with pathological Stage T3b and/or lymph node metastatic bladder cancer after radical cystectomy. Japanese Journal of Clinical Oncology. 45(10). 963–967. 2 indexed citations
11.
Kurosawa, Kazuhiro, et al.. (2015). [Clinicopathological Study and Treatment Outcome of Retroperitoneal Soft Tissue Sarcoma].. PubMed. 61(11). 419–26.
12.
Fujii, Yoichi, Masaomi Ikeda, Kazuhiro Kurosawa, et al.. (2014). Different clinicopathological features between patients who developed early and late recurrence following surgery for renal cell carcinoma. International Journal of Clinical Oncology. 20(4). 802–807. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinyeong Lim Breakdown of academic impact, for papers by Shanghua Jing Breakdown of academic impact, for papers by Maitri Kalra Breakdown of academic impact, for papers by Stefania Pipitone Breakdown of academic impact, for papers by Sumito Shingaki Breakdown of academic impact, for papers by Sophie Shifman Breakdown of academic impact, for papers by Kerstie Johnson Breakdown of academic impact, for papers by Hasan Mirza Breakdown of academic impact, for papers by L. Manahan Breakdown of academic impact, for papers by Amanda J. Loch
Rankless by CCL
2026